The Financial Post reports in its Wednesday edition that the long-awaited easing in U.S. cannabis laws, known as rescheduling, is still elusive, leaving in place suffocating restrictions on sales due to marijuana's classification alongside drugs including LSD and heroin. A Canadian Press dispatch to the Post says that has led cannabis companies to find other businesses, including alcohol and hemp. Optimism that the U.S. will change its stance on marijuana increased this year when the Drug Enforcement Administration said it was reviewing the drug's status. President Joe Biden came out in favour of the change in May. Cannabis stocks rose Monday after former president Donald Trump did likewise. The DEA will hear expert opinions on the proposed classification in December. Cannabis companies have also taken to selling hemp-based products. Canopy Growth, through its subsidiary Wana, announced its first intoxicating hemp product last month to be sold through a newly launched direct-to-consumer marketplace. Hemp, a cousin of marijuana used to make intoxicating drinks and edibles, can be legally sold and shipped nationwide due to a loophole in the Farm Bill. That legislation is up for review later this year.